DRKS00031547
Recruiting
Not Applicable
Extended monitoring and success evaluation of percutaneous catheter-supported AV valve interventions using pulse contour analysis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- I34.0
- Sponsor
- Klinik für Anästhesiologie
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Therapy of severe AV valve regurgitation by percutaneous catheter\-based intervention.
- •\- Capacity to consent
Exclusion Criteria
- •\- Pre\-existing circulatory disorders of the upper extremities
- •\- Emergency intervention
- •\- Cardiogenic shock
- •\- Lack of informed consent for study participation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Progress monitoring for the evaluation of complications that occur in direct or indirect connection with the compression therapy / thrombin injection to treat catheter-associated complications (pseudoaneurysm)I72.4Aneurysm and dissection of artery of lower extremityDRKS00009961Gefäßzentrum Klinikum Darmstadt GmbH238
Active, not recruiting
Not Applicable
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensEUCTR2009-016560-36-PLF. Hoffmann-La Roche Ltd650
Active, not recruiting
Not Applicable
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensChronic Hepatitis CMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2009-016560-36-ATF. Hoffmann-La Roche Ltd650
Active, not recruiting
Phase 1
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing RegimensChronic Hepatitis CMedDRA version: 14.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2009-016560-36-DEF. Hoffmann-La Roche Ltd650
Active, not recruiting
Not Applicable
A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatmentresistant mutations or the durability of sustained virological response (SVR) in patients treated with DAAcontaining regimens for chronic hepatitis C infection (CHC). - NDChronic Hepatitis CMedDRA version: 9.1Level: LLTClassification code 10008912EUCTR2009-016560-36-ITF. Hoffmann-La Roche Ltd650